GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Medikit Co 7749.T · JPY

Health Care · Tokyo Stock Exchange · 🇯🇵 Japan

Compare

2,701

+2.62%

Close of 9 Nov 2026, in JPY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in JPY, from our data supplier.

FY2026

Revenue

¥23.78bn

FY2017FY2026

Net income

¥3.01bn

FY2017FY2026

Free cash flow

¥1.29bn

FY2017FY2026

Shareholders' equity

¥46.78bn

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue¥23.78bn¥22.55bn¥21.85bn¥21.61bn¥20.13bn¥19.31bn¥19.89bn¥18.50bn¥17.45bn¥16.85bn
Gross profit¥8.44bn¥8.33bn¥8.42bn¥8.05bn¥7.95bn¥7.36bn¥8.08bn¥7.46bn¥7.27bn¥7.02bn
Research and development¥299.3m¥271.5m¥278.4m¥323.1m¥328.0m¥358.0m¥218.5m¥239.4m¥242.9m¥237.2m
Operating income¥4.27bn¥4.49bn¥4.67bn¥4.11bn¥4.42bn¥3.77bn¥4.32bn¥3.86bn¥3.63bn¥3.51bn
Net income¥3.01bn¥3.01bn¥3.07bn¥2.86bn¥2.99bn¥2.66bn¥2.89bn¥2.58bn¥2.47bn¥2.30bn
Diluted earnings per share207.63207.08208.57170.56178.29158.24171.09151.95145.39135.40

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assets¥53.27bn¥52.47bn¥51.00bn¥53.19bn¥51.10bn¥49.97bn¥49.08bn¥46.34bn¥44.36bn¥42.25bn
Cash and short-term investments¥22.45bn¥23.06bn¥25.11bn¥29.09bn¥29.62bn¥28.99bn¥28.33bn¥27.05bn¥25.72bn¥24.40bn
Total liabilities¥6.49bn¥7.31bn¥6.87bn¥5.89bn¥5.33bn¥6.33bn¥6.91bn¥6.29bn¥6.21bn¥5.90bn
Debt¥19.0m—−¥153.5m¥766.9m¥747.3m¥729.7m———¥688.5m
Shareholders' equity¥46.78bn¥45.16bn¥44.13bn¥47.29bn¥45.77bn¥43.64bn¥42.17bn¥40.05bn¥38.15bn¥36.36bn
Shares outstanding14m15m15m17m17m17m17m17m17m17m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations¥4.74bn¥3.56bn¥4.84bn¥4.48bn¥3.19bn¥3.64bn¥3.55bn¥3.80bn¥3.12bn¥2.95bn
Capital spending−¥3.44bn−¥3.82bn−¥1.69bn−¥982.7m−¥1.78bn−¥1.54bn−¥1.45bn−¥1.71bn−¥1.05bn−¥918.6m
Free cash flow¥1.29bn−¥254.9m¥3.15bn¥3.50bn¥1.41bn¥2.10bn¥2.11bn¥2.09bn¥2.07bn¥2.03bn
Dividends paid−¥1.41bn−¥1.33bn−¥1.75bn−¥1.51bn−¥834.7m−¥847.5m−¥762.9m−¥635.8m−¥635.8m−¥593.2m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue¥6.37bn¥5.32bn¥6.54bn¥6.03bn¥5.89bn¥5.21bn¥6.06bn¥5.66bn
Gross profit¥2.40bn¥1.38bn¥2.59bn¥2.31bn¥2.16bn¥1.73bn¥2.41bn¥2.10bn
Operating income¥1.27bn¥614.1m¥1.41bn¥1.22bn¥1.02bn¥856.7m¥1.41bn¥1.14bn
Net income¥523.4m¥769.2m¥885.9m¥958.7m¥392.2m¥858.1m¥876.6m¥873.4m
Diluted earnings per share36.1553.1360.8865.8826.9558.9759.5759.35
Total assets¥52.86bn¥53.27bn¥51.95bn¥52.48bn¥51.50bn¥52.47bn¥50.04bn¥52.07bn
Cash and short-term investments¥21.49bn¥22.45bn¥21.65bn¥22.62bn¥21.85bn¥23.06bn¥21.77bn¥24.34bn
Debt¥4.0m¥5.1m¥722,000¥1.4m¥2.0m———
Shareholders' equity¥46.65bn¥46.78bn¥45.61bn¥45.74bn¥44.80bn¥45.16bn¥44.16bn¥44.66bn

Financial ratios

Data as of 19 Sept 2026

FY2026FY2025FY2025FY2024FY2024FY2023FY2023FY2022FY2022FY2021FY2021FY2020FY2005
Gross margin35.5%—36.9%—38.5%—37.2%—39.5%—38.1%——
Operating margin18.0%—19.9%—21.4%—19.0%—21.9%—19.5%——
Net margin12.6%—13.4%—14.0%—13.3%—14.9%—13.8%——
Return on equity6.4%—6.7%—7.0%—6.1%—6.5%—6.1%——
Return on assets5.6%—5.7%—6.0%—5.4%—5.9%—5.3%——
Revenue growth5.4%—3.2%—1.1%—7.3%—4.2%—-2.9%——
Earnings growth-0.2%—-1.8%—7.2%—-4.3%—12.6%—-7.9%——
Current ratio6.25x—5.40x—6.03x—8.17x—8.73x—9.06x——
Debt to equity0.00x———-0.00x—0.02x—0.02x—0.02x—0.04x
Equity ratio87.8%—86.1%—86.5%—88.9%—89.6%—87.3%——
Interest coverage557.15x—593.08x—613.29x—544.99x—600.19x—524.97x——
R&D as a share of sales1.3%—1.2%—1.3%—1.5%—1.6%—1.9%——
Buybacks as a share of market value—1.1%—12.4%—-0.1%—0.1%—0.5%—0.4%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue3.2%4.3%4.2%
Operating income1.3%2.5%1.7%
Net income1.6%2.5%2.7%

Average margins

Over each period

1 year3 years5 years10 years
Gross margin36.2%37.0%37.6%39.1%
Operating margin18.9%19.5%19.9%20.5%
Net margin13.0%13.3%13.6%13.8%

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings12.914.612.917.014.418.020.123.719.519.8
Price to sales1.61.91.82.32.12.52.93.32.82.7

Dividends and splits

Per share, in the currency the company pays

Paid for 20 years. Last went ex-dividend on 29 Sept 2026.

FY2027FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Paid in the year50.00145.0090.0075.0090.0050.0050.0045.00
  • 2-for-1 split · 30 Mar 2020
  • 10-for-1 split · 26 Sept 2012
  • 2-for-1 split · 26 May 2006

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.